🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06707324
Starting soon Not applicable

Analgesic Efficacy of Transversus Abdominis Plane Block Versus External Oblique Block in Patients Undergoing Elective Laparoscopic Cholecystectomy

NCT06707324 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2024-12-01
Last updated
2024-12-03

Condition(s) studied

Transversus Abdominis Plane BlockExternal Oblique BlockLaparoscopic Cholecystectomy

Investigational drug(s) / intervention(s)

drug injected between the rectus abdominis muscle and the transversus abdominis muscledrug injected in the external oblique intercostal plane on both sides

drug injected between the rectus abdominis muscle and the transversus abdominis muscle: 20 ml of 0.25% bupivacaine + 8 mg dexamethasone between the rectus abdominis muscle and the transversus abdominis muscle on both sides

drug injected in the external oblique intercostal plane on both sides: 20 ml of 0.25% bupivacaine+ 8 mg dexamethasone into the external oblique intercostal plane on both sides

Study summary

Postoperative pain management is a critical aspect of recovery following laparoscopic cholecystectomy, a commonly performed procedure for symptomatic gallbladder disease. Effective analgesia not only enhances patient comfort but also facilitates early mobilization, reduces the incidence of complications, and improves overall outcomes.

Oblique subcostal transversus abdominis plane block (OSTAP), one of the regional anesthesia techniques, is used in middle and upper abdominal surgeries OSTAP blocks the T6-9 intercostal nerves between the rectus abdominis and transversus abdominis muscle. Many studies have shown that OSTAP block reduces the postoperative analgesic and opioid requirement and improves the quality of postoperative pain control.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: 1. Adult patients aged 18-60 years. 2. Gender: Both males and females. 3. BMI less than 35 kg/m2 4. Scheduled for laparoscopic cholecystectomy surgery 5. American Society of Anesthesiologists - ASA - I \& II Exclusion Criteria: 1-ASA physical status more than II. 2-History of allergic response to local anaesthetics or any of the medications used in the study \-

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of medicine, Assiut University, Assiut, Egypt, Asyut Egypt

More Assiut University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06707324 on ClinicalTrials.gov ↗ ← All trials in Egypt